C12N 2760/20062
By genetic engineering
Official title: by genetic engineering
C12N2760/20062 (By genetic engineering) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 4
- Inventors
- 8
- Latest grant
- 3 Sep 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
By publication year.
Recent patents
- Attenuated virus having multiple hosts3 Sep 2019US 10,400,220 B2The Research Foundation for The State University of New York
- Oncolytic rhabdovirus20 Feb 2018US 9,896,664 B2Turnstone Limited Partnership
- Oncolytic rhabdovirus2 Jun 2015US 9,045,729 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Recoded arbovirus and vaccines3 Jan 2019US 2019/0002837 A1The Research Foundation for The State University of New York
- Oncolytic rhabdovirus1 Oct 2015US 2015/0275185 A1Children's Hospital of Eastern Ontario Research Institute Inc.
- Oncolytic rhabdovirus1 Nov 2012US 2012/0275999 A1Children's Hospital of Eastern Ontario Research Institute Inc.
Most cited
By later US patents